Havard H. Fretheim

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Treatment patterns, disease progression and survival in Sjögren disease-associated interstitial lung disease: a multicentre European cohort study.

Treatment patterns, disease progression and survival in Sjögren disease-associated interstitial lung disease: a multicentre European cohort study.

Journal: Journal of autoimmunity

Published: March 10, 2026

Clinical Profiles and Lung Function Trajectories of Patients With Idiopathic Inflammatory Myopathy Associated Interstial Lung Disease: A Comparative Study of Pulmonology and Rheumatology Settings.

Clinical Profiles and Lung Function Trajectories of Patients With Idiopathic Inflammatory Myopathy Associated Interstial Lung Disease: A Comparative Study of Pulmonology and Rheumatology Settings.

Journal: Chest

Published: September 17, 2025

A screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC score.

A screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC score.

Journal: Rheumatology (Oxford, England)

Published: April 14, 2025

A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis.

A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis.

Journal: Rheumatology (Oxford, England)

Published: October 22, 2024

Validation of a semi-quantitative method to assess interstitial lung disease severity and progression in systemic sclerosis by standard and low-dose HRCT scans.

Validation of a semi-quantitative method to assess interstitial lung disease severity and progression in systemic sclerosis by standard and low-dose HRCT scans.

Journal: RMD open

Published: September 24, 2024

Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study.

Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study.

Journal: The Lancet. Rheumatology

Published: August 01, 2024

Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trial.

Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trial.

Journal: The Lancet. Rheumatology

Published: July 26, 2024

Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohort.

Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohort.

Journal: RMD open

Published: August 29, 2023

Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis.

Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis.

Journal: Rheumatology (Oxford, England)

Published: December 19, 2022

Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension.

Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension.

Journal: Frontiers in immunology

Published: July 11, 2022

Serum markers of cardiac complications in a systemic sclerosis cohort.

Serum markers of cardiac complications in a systemic sclerosis cohort.

Journal: Scientific reports

Published: December 04, 2021

Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries.

Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries.

Journal: ERJ open research

Published: October 22, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026